BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thorne K, Alrubaiy L, Akbari A, Samuel DG, Morrison-Rees S, Roberts SE. Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin: a systematic literature review. Eur J Gastroenterol Hepatol 2016;28:369-82. [PMID: 26825217 DOI: 10.1097/MEG.0000000000000568] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Eronen H, Oksanen P, Jussila A, Huhtala H, Helavirta I, Ilus T. Long-term outcomes of patients with acute severe ulcerative colitis treated with cyclosporine rescue therapy. Scand J Gastroenterol 2022;:1-6. [PMID: 36384352 DOI: 10.1080/00365521.2022.2143727] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Johnsen K, Florholmen J, Moe ØK, Gundersen M, Beilfuss J, Kileng H, Sørbye SW, Goll R. Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study. BMC Gastroenterol 2022;22:459. [DOI: 10.1186/s12876-022-02522-4] [Reference Citation Analysis]
3 Dulai PS, Jairath V. A Microsimulation Model to Project the 5-Year Impact of Using Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Acute Flares. Dig Dis Sci 2021;66:3740-52. [PMID: 33185788 DOI: 10.1007/s10620-020-06707-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Festa S, Scribano ML, Pugliese D, Bezzio C, Principi M, Ribaldone DG, Allocca M, Mocci G, Bodini G, Spagnuolo R, Vernia P, Mazzuoli S, Costa F, Barberio B, Cosintino R, Zerboni G, Aratari A, Armuzzi A, Papi C. Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study. United European Gastroenterol J 2021;9:507-16. [PMID: 33259773 DOI: 10.1177/2050640620977405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Worley G, Almoudaris A, Bassett P, Segal J, Akbar A, Ghosh S, Aylin P, Faiz O. Colectomy rates for ulcerative colitis in England 2003-2016. Aliment Pharmacol Ther 2021;53:484-98. [PMID: 33264468 DOI: 10.1111/apt.16202] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
6 Bartoszek A, Makaro A, Bartoszek A, Kordek R, Fichna J, Salaga M. Walnut Oil Alleviates Intestinal Inflammation and Restores Intestinal Barrier Function in Mice. Nutrients 2020;12:E1302. [PMID: 32370215 DOI: 10.3390/nu12051302] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
7 Ghoz H, Kesler A, Hoogenboom SA, Gavi F, Brahmbhatt B, Cangemi J, Kröner PT. Decreasing Colectomy Rates in Ulcerative Colitis in the Past Decade: Improved Disease Control? J Gastrointest Surg 2020;24:270-7. [PMID: 31797257 DOI: 10.1007/s11605-019-04474-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
8 Fradet C, Kern J, Atanasov P, Wirth D, Borsi A. Impact of surgery and its complications in ulcerative colitis patients in clinical practice: A systematic literature review of real-world evidence in Europe. International Journal of Surgery Open 2020;22:22-32. [DOI: 10.1016/j.ijso.2019.11.010] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Viscido A, Papi C, Latella G, Frieri G. Has infliximab influenced the course and prognosis of acute severe ulcerative colitis? Biologics 2019;13:23-31. [PMID: 31114154 DOI: 10.2147/BTT.S179006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
10 Holmer C, Kreis M. Operative Therapie der Colitis ulcerosa: Indikation, Ausmaß und Techniken. coloproctology 2019;41:13-21. [DOI: 10.1007/s00053-018-0319-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
11 Kuehn F, Hodin RA. Impact of Modern Drug Therapy on Surgery: Ulcerative Colitis. Visc Med 2018;34:426-31. [PMID: 30675487 DOI: 10.1159/000493492] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
12 Liu YJ, Fan H, Zhen WW, Yu X, Chen JT, Wang CD. Pooled analysis of the comparative efficacy between tacrolimus and infliximab for ulcerative colitis. Medicine (Baltimore) 2018;97:e11440. [PMID: 30095612 DOI: 10.1097/MD.0000000000011440] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
13 Jeon SR. Is Adsorptive Granulocyte and Monocyte Apheresis Effective as an Alternative Treatment Option in Patients with Ulcerative Colitis? Gut Liver 2017;11:171-2. [PMID: 28274106 DOI: 10.5009/gnl17028] [Reference Citation Analysis]
14 Johnsen KM, Goll R, Hansen V, Olsen T, Rismo R, Heitmann R, Gundersen MD, Kvamme JM, Paulssen EJ, Kileng H, Johnsen K, Florholmen J. Repeated intensified infliximab induction - results from an 11-year prospective study of ulcerative colitis using a novel treatment algorithm. Eur J Gastroenterol Hepatol 2017;29:98-104. [PMID: 27749779 DOI: 10.1097/MEG.0000000000000753] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]